BUSINESS BRIEFING / PHARMACEUTICALS
- Share via
TIMES WIRE REPORTS
The Food and Drug Administration will require two smoking-cessation drugs, Chantix and Zyban, to carry the agency’s strongest safety warning.
The “black box” warning is in response to reports of people experiencing depression, suicidal thoughts or unusual changes in behavior while taking the drugs.
The FDA is also requiring an additional study on the drugs to determine the extent of the side effects.
Chantix is made by Pfizer Inc. Zyban is made by GlaxoSmithKline.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
